Nadia Whittley
Directeur Général chez Arquer Diagnostics Ltd.
Profil
Nadia Whittley is currently the Chief Executive Officer and Director at Arquer Diagnostics Ltd.
She previously worked as the Chief Executive Officer and Managing Director at Alium Medical Ltd.
and as a Director at Peptonic Medical AB.
Postes actifs de Nadia Whittley
Sociétés | Poste | Début |
---|---|---|
Arquer Diagnostics Ltd.
Arquer Diagnostics Ltd. Medical/Nursing ServicesHealth Services Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom. | Directeur Général | - |
Anciens postes connus de Nadia Whittley
Sociétés | Poste | Fin |
---|---|---|
Alium Medical Ltd.
Alium Medical Ltd. Drugstore ChainsRetail Trade Alium Medical Ltd. distributes pharmaceutical products. It provides clinical trial supplies. The company was founded by Ben Rabin in 1998 and its headquarters in Borehamwood, the United Kingdom. | Directeur Général | - |
PEPTONIC MEDICAL AB | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PEPTONIC MEDICAL AB | Health Technology |
Entreprise privées | 2 |
---|---|
Alium Medical Ltd.
Alium Medical Ltd. Drugstore ChainsRetail Trade Alium Medical Ltd. distributes pharmaceutical products. It provides clinical trial supplies. The company was founded by Ben Rabin in 1998 and its headquarters in Borehamwood, the United Kingdom. | Retail Trade |
Arquer Diagnostics Ltd.
Arquer Diagnostics Ltd. Medical/Nursing ServicesHealth Services Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom. | Health Services |